Clinical trial

A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal…

NCT00190515 · Haruhiko Fukuda, Other · Completed

Key facts

NCT number NCT00190515
Title A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)
Official title Randomized Phase III Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)
Lead sponsor Haruhiko Fukuda, Other
Collaborators Ministry of Health, Labour and Welfare, Japan
Status Completed
Phase Phase 3
Study type Interventional
Conditions Colorectal Neoplasms
Intervention type Drug
Interventions 5FU+l-leucovorin, UFT+Leucovorin
Enrollment 1,101
Start date Feb 1, 2003
Primary completion Nov 1, 2011
Completion Nov 1, 2011
First posted Sep 19, 2005
Last update posted Sep 22, 2016
Countries Japan

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies